U.S. Markets closed

Interleukin Genetics, Inc. (ILIU)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.005-0.000 (-3.846%)
At close: 2:08PM EDT
People also watch
GOVXSNWVPBIOICCCINNV
Full screen
Previous Close0.005
Open0.005
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.005 - 0.005
52 Week Range0.005 - 0.220
Volume39,755
Avg. Volume203,392
Market Cap1.15M
Beta0.06
PE Ratio (TTM)-0.12
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Interleukin Genetics, Inc. :ILIU-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016
    Capital Cube9 months ago

    Interleukin Genetics, Inc. :ILIU-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016

    Categories: Yahoo Finance Get free summary analysis Interleukin Genetics, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Interleukin Genetics, Inc. – Psychemedics Corporation, Genomic Health, Inc., RadNet, Inc., Quest Diagnostics Incorporated, Myriad Genetics, Inc. and Trovagene, Inc. (PMD-US, GHDX-US, RDNT-US, DGX-US, MYGN-US and TROV-US) that ... Read more (Read more...)

  • Zacks Small Cap Researchlast year

    ILIU: Making Progress on PerioPredict Adoption

    By Brian Marckx, CFA OTC:ILIU Q4 2015 : PerioPredict Adoption Still Slow, But Making Progress. Top-Notch Clinical Advisory Board Brought On Interleukin Genetics (OTC:ILIU) reported financial results for ...

  • Zacks Small Cap Researchlast year

    ILIU Inks Deal With Metagenics for PerioPredict

    By Brian Marckx, CFA OTC:ILIU Metagenics Will Utilize PerioPredict in Benefit Plans : Interleukin Genetics (OTC:ILIU) announced last week that Metagenics will use PerioPredict in their employee benefit ...